Details of the Drug Combinations

General Information of This Drug (ID: DMT9FH3)

Drug Name

Terlipressin DMT9FH3

Synonyms

Glypressin; Lucassin; Terlipressina; Terlipressine; Terlipressinum; Glypressin (TN); HS-2028; Terlipressin [BAN:INN]; Terlipressina [INN-Spanish]; Terlipressine [INN-French]; Terlipressinum [INN-Latin]; N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin

Indication

Disease Entry	ICD 11	Status	REF
Hypertension	BA00-BA04	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Vasoconstrictor Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Norepinephrine + Terlipressin	DCE22ZE	Norepinephrine	Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS	[2]
------------------------------------------------------------------------------------

References

1	Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):207-17.
2	ClinicalTrials.gov (NCT01637454) TYPE 2 HEPATORENAL SYNDROME